166 related articles for article (PubMed ID: 8671392)
1. Endothelial cell proliferation in the endometrium of women with menorrhagia and in women following endometrial ablation.
Kooy J; Taylor NH; Healy DL; Rogers PA
Hum Reprod; 1996 May; 11(5):1067-72. PubMed ID: 8671392
[TBL] [Abstract][Full Text] [Related]
2. Altered vascular smooth muscle cell differentiation in the endometrial vasculature in menorrhagia.
Biswas Shivhare S; Bulmer JN; Innes BA; Hapangama DK; Lash GE
Hum Reprod; 2014 Sep; 29(9):1884-94. PubMed ID: 25006206
[TBL] [Abstract][Full Text] [Related]
3. Menstrual blood loss measured 5-6 years after endometrial ablation.
Teirney R; Arachchi GJ; Fraser IS
Obstet Gynecol; 2000 Feb; 95(2):251-4. PubMed ID: 10674589
[TBL] [Abstract][Full Text] [Related]
4. Endometrial endothelial cell proliferation in long-term users of subdermal levonorgestrel.
Goodger AM; Rogers PA; Affandi B
Hum Reprod; 1994 Sep; 9(9):1647-51. PubMed ID: 7530724
[TBL] [Abstract][Full Text] [Related]
5. Expression of aquaporin-1 in endometrial blood vessels in menorrhagia.
Mints M; Hildenbrand A; Lalitkumar LP; Andersson S; Nielsen S; Gemzell-Danielsson K; Stavreus-Evers A
Int J Mol Med; 2007 Mar; 19(3):407-11. PubMed ID: 17273788
[TBL] [Abstract][Full Text] [Related]
6. Cortisol inactivation by 11beta-hydroxysteroid dehydrogenase-2 may enhance endometrial angiogenesis via reduced thrombospondin-1 in heavy menstruation.
Rae M; Mohamad A; Price D; Hadoke PW; Walker BR; Mason JI; Hillier SG; Critchley HO
J Clin Endocrinol Metab; 2009 Apr; 94(4):1443-50. PubMed ID: 19158196
[TBL] [Abstract][Full Text] [Related]
7. Endometrial vascular smooth muscle oestrogen and progesterone receptor distribution in women with and without menorrhagia.
Rogers PA; Lederman F; Kooy J; Taylor NH; Healy DL
Hum Reprod; 1996 Sep; 11(9):2003-8. PubMed ID: 8921080
[TBL] [Abstract][Full Text] [Related]
8. Endometrial microvascular growth in normal and dysfunctional states.
Rogers PA; Lederman F; Taylor N
Hum Reprod Update; 1998; 4(5):503-8. PubMed ID: 10027602
[TBL] [Abstract][Full Text] [Related]
9. Psychiatric morbidity following endometrial ablation and its association with genuine menorrhagia.
Wright B; Gannon MJ; Greenberg M; House A; Rutherford T
BJOG; 2003 Apr; 110(4):358-63. PubMed ID: 12699796
[TBL] [Abstract][Full Text] [Related]
10. Expression of vascular endothelial growth factor receptor-3 in the endometrium in menorrhagia.
Mints M; Blomgren B; Palmblad J
Int J Mol Med; 2007 Jun; 19(6):909-13. PubMed ID: 17487423
[TBL] [Abstract][Full Text] [Related]
11. Wall discontinuities and increased expression of vascular endothelial growth factor-A and vascular endothelial growth factor receptors 1 and 2 in endometrial blood vessels of women with menorrhagia.
Mints M; Hultenby K; Zetterberg E; Blomgren B; Falconer C; Rogers R; Palmblad J
Fertil Steril; 2007 Sep; 88(3):691-7. PubMed ID: 17336974
[TBL] [Abstract][Full Text] [Related]
12. Endometrial vascular development in heavy menstrual bleeding: altered spatio-temporal expression of endothelial cell markers and extracellular matrix components.
Biswas Shivhare S; Bulmer JN; Innes BA; Hapangama DK; Lash GE
Hum Reprod; 2018 Mar; 33(3):399-410. PubMed ID: 29309596
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis, vascular endothelial growth factor and the endometrium.
Smith SK
Hum Reprod Update; 1998; 4(5):509-19. PubMed ID: 10027603
[TBL] [Abstract][Full Text] [Related]
14. Endometrial ablation for von Willebrand disease-related menorrhagia--experience with seven cases.
Rubin G; Wortman M; Kouides PA
Haemophilia; 2004 Sep; 10(5):477-82. PubMed ID: 15357774
[TBL] [Abstract][Full Text] [Related]
15. Endometrial endothelial cell proliferation during the menstrual cycle.
Goodger AM; Rogers PA
Hum Reprod; 1994 Mar; 9(3):399-405. PubMed ID: 7516347
[TBL] [Abstract][Full Text] [Related]
16. Cavaterm thermal balloon endometrial ablation versus hysteroscopic endometrial resection to treat menorrhagia: the French, multicenter, randomized study.
Brun JL; Raynal J; Burlet G; Galand B; Quéreux C; Bernard P
J Minim Invasive Gynecol; 2006; 13(5):424-30. PubMed ID: 16962526
[TBL] [Abstract][Full Text] [Related]
17. Validation of a method of treating menorrhagia by endometrial ablation.
Phipps JH; Smith T; Dymek P; Hesp R; Lewis BV
Clin Phys Physiol Meas; 1992 Aug; 13(3):273-80. PubMed ID: 1424477
[TBL] [Abstract][Full Text] [Related]
18. Microvascular density, vascular endothelial growth factor A, and its receptors in endometrial blood vessels in patients with menorrhagia.
Mints M; Blomgren B; Falconer C; Fianu-Jonasson A; Palmblad J
Fertil Steril; 2005 Sep; 84(3):692-700. PubMed ID: 16169405
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis: a new theory for endometriosis.
Healy DL; Rogers PA; Hii L; Wingfield M
Hum Reprod Update; 1998; 4(5):736-40. PubMed ID: 10027628
[TBL] [Abstract][Full Text] [Related]
20. The morphologic characteristics of menstrual hemostasis in patients with unexplained menorrhagia.
Hourihan HM; Sheppard BL; Bonnar J
Int J Gynecol Pathol; 1989; 8(3):221-9. PubMed ID: 2767871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
